Produits biochimiques et réactifs
Les biochimiques et réactifs sont des substances fondamentales pour la recherche et le développement dans des domaines tels que la biotechnologie, la biologie moléculaire, la pharmacologie et la médecine. Ces produits sont essentiels pour une variété d'applications, y compris la synthèse de composés, l'analyse d'échantillons biologiques, la recherche sur les processus métaboliques et la production de médicaments. Chez CymitQuimica, nous proposons une large sélection de biochimiques et réactifs de haute qualité et pureté, adaptés à divers besoins scientifiques et industriels. Notre catalogue comprend des enzymes, des anticorps, des acides nucléiques, des acides aminés et de nombreux autres produits, tous conçus pour soutenir les chercheurs et les professionnels dans leurs projets de recherche et développement, garantissant des résultats fiables et reproductibles.
Sous-catégories appartenant à la catégorie "Produits biochimiques et réactifs"
- Biomolécules(99.127 produits)
- Par Biological Target(99.160 produits)
- Par usage/effets pharmacologiques(6.787 produits)
- Cryoconservation et composés associés aux cryoconservateurs(21 produits)
- Désinfectants, additifs pour les fluides pour bains chauffants et composés apparentés(28 produits)
- Hormones(346 produits)
- Biologie végétale(6.742 produits)
- Métabolites secondaires(14.222 produits)
130581 produits trouvés pour "Produits biochimiques et réactifs"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
DABCYL-(Asn670,Leu671)-Amyloid b/A4 Protein Precursor770 (661-675)-EDANS ammonium salt
CAS :<p>Please enquire for more information about DABCYL-(Asn670,Leu671)-Amyloid b/A4 Protein Precursor770 (661-675)-EDANS ammonium salt including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formule :C103H146N22O32SDegré de pureté :Min. 95%Masse moléculaire :2,236.46 g/mol(Arg17)-Amyloid b-Protein (1-42) trifluoroacetate salt
CAS :<p>Please enquire for more information about (Arg17)-Amyloid b-Protein (1-42) trifluoroacetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formule :C203H312N58O60SDegré de pureté :Min. 95%Masse moléculaire :4,557.07 g/molTrodusquemine
CAS :<p>Inhibitor of protein tyrosine phosphatase PTP1B</p>Formule :C37H72N4O5SDegré de pureté :Min. 95%Masse moléculaire :685.06 g/mol(Gly22)-Amyloid b-Protein (1-40) trifluoroacetate salt
CAS :<p>Please enquire for more information about (Gly22)-Amyloid b-Protein (1-40) trifluoroacetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formule :C191H291N53O56SDegré de pureté :Min. 95%Masse moléculaire :4,257.74 g/molAG 14361
CAS :<p>AG 14361 is a potent inhibitor designed to target the interaction between the tumor suppressor protein p53 and the murine double minute 2 (MDM2) oncoprotein. It is synthetically derived, offering researchers a tool to perturb a critical protein-protein interaction involved in the regulation of the cell cycle and apoptosis. The mode of action involves the disruption of the p53-MDM2 interaction, leading to the stabilization and activation of p53. This results in the induction of p53-dependent transcriptional activity, facilitating cell cycle arrest and apoptosis in cancerous cells.</p>Formule :C19H20N4ODegré de pureté :Min. 98 Area-%Couleur et forme :PowderMasse moléculaire :320.39 g/molFmoc-Tyr(tBu)-Ser(Psi(Me,Me)Pro)-OH
CAS :<p>Please enquire for more information about Fmoc-Tyr(tBu)-Ser(Psi(Me,Me)Pro)-OH including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formule :C34H38N2O7Degré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :586.67 g/molPV-10
CAS :<p>PV-10 is a peptide that activates ion channels. It is an agonist for the nicotinic acetylcholine receptor (nAChR) and a low-affinity antagonist for the N-methyl-D-aspartate receptor (NMDAR). PV-10 binds to specific sites on the nAChR, which causes the channel to open and allow ions to flow into the cell. This leads to depolarization of the membrane, which triggers an action potential in neurons. PV-10 is also able to bind to other proteins such as NR1 subunits of NMDARs and alpha 7 subunits of nAChRs. These interactions inhibit the function of these receptors and prevent them from opening their channels. This prevents calcium influx into cells, blocking neurotransmitter release and preventing the activation of downstream pathways that lead to neuronal death. PV-10 has been shown to be selective for certain types of ion channels over others</p>Formule :C20H4Cl4I4O5Degré de pureté :Min. 95%Masse moléculaire :973.7 g/molGLP-1 (1-37) (human, bovine, guinea pig, mouse, rat) trifluoroacetate salt
CAS :<p>GLP-1 (1-37) (human, bovine, guinea pig, mouse, rat) trifluoroacetate salt is a posttranslational modification of the endogenous human hormone GLP-1. It is a synthetic form of this hormone that has been modified to allow for improved stability and solubility. This peptide is found in the pancreatic alpha cells and intestinal L cells and stimulates the release of insulin from pancreatic beta cells. GLP-1 (1-37) (human, bovine, guinea pig, mouse, rat) trifluoroacetate salt has also been shown to increase glucose uptake by muscle tissue as well as stimulate the release of incretin hormones such as glucagon-like peptide 1 and gastric inhibitory polypeptide. GLP-1 (1-37) (human, bovine, guinea pig, mouse, rat) trifluoroacetate salt</p>Formule :C186H275N51O59Degré de pureté :Min. 95%Masse moléculaire :4,169.48 g/molACY 1215
CAS :<p>Rocilinostat (ACY-1215) is an orally bioavailable, specific inhibitor of histone deacetylase 6 (HDAC6) with potential antineoplastic activity.</p>Formule :C24H27N5O3Degré de pureté :Min. 95%Masse moléculaire :433.5 g/molBC2059
CAS :<p>BC2059 is a cytosolic calcium ionophore that binds to the extracellular domain of the survivin protein, which regulates cellular proliferation and differentiation. BC2059 has been shown to inhibit the proliferation of bone cancer cells in vitro. It also inhibits the proliferation of metastatic colorectal cancer cells by binding to cyclin D2. The drug is not toxic to normal cells with low expression of survivin or cyclin D2, and it can be used for treatment in conjunction with surgery or chemotherapy for solid tumours.</p>Formule :C28H36N4O6S2Degré de pureté :Min. 95%Masse moléculaire :588.74 g/mol5-Hydroxymatrine
CAS :<p>5-Hydroxymatrine is an alkaloid compound, which is derived from the roots of Sophora plants, notably Sophora flavescens. This compound is characterized by its structure as a quinolizidine alkaloid and is a modified form of matrine, with a hydroxyl group adding to its chemical complexity.</p>Formule :C15H24N2O2Degré de pureté :Min. 95%Masse moléculaire :264.36 g/molH-D-Arg(Me)-OH acetate salt
CAS :Produit contrôlé<p>H-D-Arg(Me)-OH is a peptide that has been shown to inhibit the proliferation of cancer cells in culture. It inhibits the growth of tumor cells by blocking the activity of the oxytocin receptor, which regulates cell adhesion and migration. The H-D-Arg(Me)-OH acetate salt has also been shown to promote the differentiation of basophilic leukemia cells into normal myeloid cells. This peptide is used as a control for incubated cell cultures, such as liver cells, and can be used to study protein synthesis.</p>Formule :C7H16N4O2Degré de pureté :Min. 95%Masse moléculaire :188.23 g/molUrolithin M6
CAS :<p>Urolithin M6 is a metabolite, which is a bioactive compound derived from the metabolism of ellagitannins and ellagic acid found in certain dietary polyphenols. These polyphenols are abundant in fruits such as pomegranates, berries, and nuts. The transformation into urolithins, including Urolithin M6, is facilitated by the gut microbiota, which metabolizes these ellagitannins in the gastrointestinal tract.</p>Formule :C13H8O6Degré de pureté :Min. 95%Masse moléculaire :260.2 g/molBRD6688
CAS :<p>BRD6688 is a protein inhibitor that binds to and inhibits the activity of GABA transporters. It is a potent inhibitor of the gaba transporter (GAT) with an IC50 of 0.2 μM. BRD6688 has been shown to inhibit the acetylation of histone proteins, which are important for transcriptional regulation and gene expression. BRD6688 also has a thermodynamic inhibitory constant (Ki) of 1.4 μM and a kinetic inhibitory constant (Ki) of 0.3 μM, indicating that it binds tightly to GATs and does not dissociate easily from it. The Ki values were determined by measuring the inhibition of GAT-mediated chloride transport in cells cultured in vitro. This drug also inhibits antigen presentation in T cells by inhibiting protein synthesis and cell division, as well as histone methylation during mitosis, leading to downregulation of cell-surface antigens on B cells.</p>Formule :C16H18N4ODegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :282.34 g/molAvibactam descarbonyl
CAS :<p>Avibactam descarbonyl is a medicinal compound that has shown promise as an anticancer agent. It is an analog of kinase inhibitors, which are known to have potent anticancer activity. Avibactam descarbonyl has been shown to induce apoptosis in cancer cells and inhibit the growth of tumors in Chinese hamsters. This compound has also been found in urine samples from patients receiving avibactam therapy, suggesting that it may be a metabolite of this drug. Avibactam descarbonyl is a cyclin-dependent protein kinase inhibitor, which means that it can prevent the proliferation of cancer cells by blocking cell cycle progression. This compound has potential for use in cancer treatment due to its potent anticancer activity and ability to induce apoptosis in tumor cells.</p>Formule :C6H13N3O5SDegré de pureté :Min. 95%Masse moléculaire :239.25 g/molOctreotide acetate-d8
CAS :<p>Octreotide acetate-d8 is an analog of somatostatin, a hormone that inhibits the secretion of growth hormone and other hormones. It is used in the treatment of cancer, particularly tumors that have high levels of testosterone or somatostatin receptors. Octreotide acetate-d8 acts as an inhibitor of kinases, which are enzymes involved in cell signaling pathways that regulate cell growth and division. This drug has been shown to induce apoptosis (programmed cell death) in cancer cells by inhibiting kinase activity. Octreotide acetate-d8 has demonstrated anticancer effects in Chinese hamster ovary cells and has been used as a research tool for studying the mechanisms of action of kinase inhibitors. This drug can be detected in urine samples using mass spectrometry techniques due to its deuterium labeling at the acetate group.</p>Formule :C49H66N10O10S2Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :1,019.2 g/molDiabzi sting agonist-1
CAS :<p>Diabzi sting agonist-1 is a biological molecule that is the tautomer of diabzol. It has been shown to have antifungal properties in vitro, and is shown to be effective against bowel disease when administered orally. Diabzi sting agonist-1 binds to fungal cell walls by hydrogen bonding interactions with nitrogen atoms on the pyrazole ring. This binding leads to protonation and conformational changes that lead to the release of bound form of the drug, which inhibits cellular growth. The redox potentials of this molecule are high enough for it to be used as an electron donor or acceptor.</p>Formule :C42H51N13O7Degré de pureté :Min. 95%Masse moléculaire :849.9 g/molJDQ-443
CAS :<p>JDQ-443 is a synthetic chemical compound, which is a product of organic synthesis, with a precise mode of action targeting specific cellular enzymes. This compound functions as an enzymatic inhibitor, designed to interfere with the activity of a specific class of enzymes critical to cellular proliferation pathways. JDQ-443 exerts its effects by binding to the active sites of these enzymes, thereby preventing substrate access and subsequent catalysis.</p>Formule :C29H28ClN7ODegré de pureté :Min. 98%Masse moléculaire :526.03 g/mol5,6-Dehydro finasteride
CAS :<p>Please enquire for more information about 5,6-Dehydro finasteride including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formule :C23H34N2O2Degré de pureté :Min. 95%Masse moléculaire :370.5 g/molEndothelin-1 (human, bovine, dog, mouse, porcine, rat) acetate
CAS :<p>Endothelin-1 (ET-1) is a peptide that is produced by the endothelium. ET-1 is involved in numerous biological processes, including vasoconstriction, inflammation, and cell proliferation. Endothelin-1 (human ET-1) acetate salt H-Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-(Glu)-Cys-(Val)-Tyr-(Phe)-Cys-(His)-Leu -Asp(-Ile)-Ile(-Trp)) acetate salt is a recombinant protein that has been shown to significantly upregulate the production of endothelin in primary pulmonary hypertension. It also plays an important role in bowel disease, where it may be involved in the development of chronic inflammatory bowel disease.</p>Formule :C109H159N25O32S5•(C2H4O2)xDegré de pureté :Min. 95%Masse moléculaire :2,491.91 g/molAngiotensin I human acetate salt hydrate
CAS :<p>Angiotensin I human acetate salt hydrate is a synthetic peptide, which is a derivative of the human angiotensinogen protein. It is sourced through chemical synthesis methods that replicate the natural sequence of this protein's active fragment. The mode of action involves conversion by the enzyme angiotensin-converting enzyme (ACE) into angiotensin II, a potent vasoconstrictor, which plays a critical role in blood pressure regulation and fluid balance.</p>Formule :C62H89N17O14·xC2H4O2·yH2ODegré de pureté :Min. 95%TNO155
CAS :<p>TNO155 is an innovative therapeutic agent, commonly classified as a small-molecule inhibitor, which is derived from rational drug design based on precision oncology principles. Its mode of action involves selective inhibition of a specific protein tyrosine phosphatase, which plays a critical role in cellular signaling pathways that are often dysregulated in cancer. This inhibition effectively disrupts aberrant signaling, thereby suppressing tumor cell proliferation and inducing apoptosis in malignant cells.</p>Formule :C18H24ClN7OSDegré de pureté :Min. 95%Masse moléculaire :421.9 g/molMilvexian
CAS :<p>Milvexian is a peptide that binds to the receptor site of NMDA ion channels, inhibiting the flow of ions and leading to neuronal cell death. The molecular weight of Milvexian is 609 amu and its chemical formula is C28H40N2O2. It is used as a research tool in Cell Biology, pharmacology, and protein interactions. Milvexian has been shown to be an inhibitor for many ligands, including GABA, L-glutamate, excitatory amino acids and neuropeptides.</p>Formule :C28H23Cl2F2N9O2Degré de pureté :Min. 95%Masse moléculaire :626.4 g/molBerubicin
CAS :<p>Berubicin is an anthracycline-based chemotherapeutic agent, which is a semi-synthetic derivative sourced primarily from the bacterium Streptomyces peucetius. It operates by intercalating into DNA strands, disrupting the replication and transcription processes, which ultimately induces apoptosis in rapidly dividing tumor cells.</p>Formule :C34H35NO11Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :633.6 g/molClopidogrel
CAS :Produit contrôlé<p>Methyl (2S)-2-(2-chlorophenyl)-2-(9-thia-4-azabicyclo[4.3.0]nona-7,10-dien-4-yl)acetate, also know as Clopidogrel, is a potent inhibitor of the platelet aggregation. It reduces blood clotting by inhibiting the ADP receptor on the surface of platelets, thereby inhibiting the aggregation and adhesion of platelets. Clopidogrel has been shown to be effective in preventing thrombosis, myocardial infarction (heart attack), and stroke. Clopidogrel inhibits the activity of cytochrome P450 3A4 (CYP3A4) and p2Y 12 receptors. Clopidogrel has been shown to have synergic effects with nonsteroidal anti-inflammatory drugs (NSAIDs). The polymorphic nature of Clopidogrel can be monitored using a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for quantification in biological samples such as human serum and plasma.</p>Formule :C16H16ClNO2SDegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :321.82 g/molDenosumab
CAS :<p>Monoclonal antibody against RANKL; anti-resorptive agent for osteoperosis treatment</p>Degré de pureté :(Sec-Hplc) Min. 95 Area-%Couleur et forme :Clear LiquidPolicosanol
CAS :<p>Policosanol is a natural substance that is obtained from sugar cane. It is a mixture of various alcohols, including octacosanol, hexacosanol, heptacosanol, and octacosanol. Policosanol has been studied for its potential to treat high cholesterol levels in the blood by reducing low-density lipoprotein-cholesterol (LDL-C) and triglycerides. Animal studies have shown that policosanol can lower LDL-C and reduce the risk of heart disease by preventing the formation of plaque in the arteries. Policosanol also reduces the risk of heart attack and stroke by lowering blood pressure and decreasing platelet aggregation. It may also be used as an antioxidant or anti-inflammatory agent.</p>Formule :C20H44OPoDegré de pureté :Min. 95%Masse moléculaire :509.32165GKA 50
CAS :<p>Glucokinase activator</p>Formule :C26H28N2O6Degré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :464.51 g/molIGF-I (1-3)
CAS :<p>IGF-I (1-3) H-Gly-Pro-Glu-OH is a synthetic peptide that has been shown to be effective in treating neuronal death caused by glutamate. It binds to calcium ions and inhibits the activity of gamma-aminobutyric acid, which is an inhibitory neurotransmitter. IGF-I (1-3) H-Gly-Pro-Glu-OH also blocks fatty acid synthesis, leading to necrotic cell death. In vitro assays have shown that this drug can protect against blood group O erythrocytes from pyridoxal phosphate oxidation and protocatechuic acid binding. This drug has also been shown to increase locomotor activity in mice, as well as improve motor function in rats with experimental stroke.<br>IGF-I (1-3) H-Gly-Pro-Glu-OH is synthesized using a polymerase chain reaction technique and consists of amino acids 1 through 3 of</p>Formule :C12H19N3O6Degré de pureté :Min. 95%Masse moléculaire :301.3 g/molp3K truncated, (Lys 58 Lys 60 Lys 63) Ea(54-68)
<p>Catalogue peptide; min. 95% purity</p>Formule :C59H97N17O19Masse moléculaire :1,348.53 g/molC. difficile Toxin B (232-241)
<p>Catalogue peptide; min. 95% purity</p>Formule :C43H74N16O18Masse moléculaire :1,103.17 g/molKK4A
<p>Catalogue peptide; min. 95% purity</p>Formule :C74H138N22O19Masse moléculaire :1,640.06 g/mol[Ala18] Endothelin-1, human
<p>Catalogue peptide; min. 95% purity</p>Formule :C108H163N25O30S5Masse moléculaire :2,451.94 g/molAc-g-Endorphin
<p>Catalogue peptide; min. 95% purity</p>Formule :C85H133N19O28SMasse moléculaire :1,901.18 g/molα-CGRP (23-37) (human)
<p>Catalogue peptide; min. 95% purity</p>Formule :C74H117N21O20Masse moléculaire :1,620.89 g/mol[D-Pro4,D-Trp7,9,Nle11]-Substance P (4-11)
<p>Catalogue peptide; min. 95% purity</p>Formule :C58H77N13O10Masse moléculaire :1,116.34 g/molMyristoylated Protein Kinase C (19-31)
<p>Catalogue peptide; min. 95% purity</p>Formule :C81H144N26O26Masse moléculaire :1,754.23 g/molProdynorphin (228-256), porcine
<p>Catalogue peptide; min. 95% purity</p>Formule :C161H236N42O48Masse moléculaire :3,527.93 g/molMMP Biotinylated Substrate I
<p>Catalogue peptide; min. 95% purity</p>Formule :C53H86N14O11Masse moléculaire :1,127.43 g/molGLP-2 (rat)
<p>Catalogue peptide; min. 95% purity</p>Formule :C166H256N44O56SMasse moléculaire :3,796.22 g/mol[Lys4] Sarafotoxin S6c
<p>Catalogue peptide; min. 95% purity</p>Formule :C105H153N27O36S5Masse moléculaire :2,529.87 g/molGastrin-1, human
<p>Catalogue peptide; min. 95% purity</p>Formule :C97H125N20O31SMasse moléculaire :2,098.22 g/molBiotin-(Arg8)-Vasopressin
<p>Catalogue peptide; min. 95% purity</p>Formule :C56H79N17O14S2Masse moléculaire :1,310.55 g/molKinase Domain of Pyruvate Kinase, porcine liver
<p>Catalogue peptide; min. 95% purity</p>Formule :C32H62N12O13PMasse moléculaire :853.88 g/molβ-Endorphin (1-26), human
<p>Catalogue peptide; min. 95% purity</p>Formule :C130H208N32O38SMasse moléculaire :2,859.36 g/mol[D-Ala2]-β-Casomorphin (1-4) amide (bovine)
<p>Catalogue peptide; min. 95% purity</p>Formule :C26H33N5O5Masse moléculaire :495.58 g/mol[D-Phe7] a-MSH, amide
<p>Catalogue peptide; min. 95% purity</p>Formule :C77H109N21O19SMasse moléculaire :1,664.92 g/molBiotin-Gastrin (1-17)
<p>Catalogue peptide; min. 95% purity</p>Formule :C107H140N22O34S2Masse moléculaire :2,342.56 g/molDefensin (human) HNP-2
<p>Catalogue peptide; min. 95% purity</p>Formule :C147H217N43O37S6Masse moléculaire :3,370.94 g/molProstaglandin F2a
CAS :<p>Natural prostaglandin; induces uterine contractions; abortifacient</p>Formule :C20H34O5Degré de pureté :Min. 95%Couleur et forme :Colorless PowderMasse moléculaire :354.48 g/molCreatine phosphate monosodium salt hexahydrate
CAS :<p>Phosphate reservoir in muscles, aiding conversion of ADP to ATP</p>Formule :C4H10N3O5P·Na·6H2OCouleur et forme :PowderMasse moléculaire :342.19 g/molAngiotensinogen (1-14), human
<p>Catalogue peptide; min. 95% purity</p>Formule :C83H122N24O19Masse moléculaire :1,760.05 g/molBiotin-Amyloid β-Protein (1-40)
<p>Catalogue peptide; min. 95% purity</p>Formule :C204H309N55O60S2Masse moléculaire :4,556.20 g/molSendai Virus Nucleoprotein (321-336)
<p>Catalogue peptide; min. 95% purity</p>Formule :C85H110N20O23Masse moléculaire :1,779.93 g/molADP-Ribosylation Factor 6, ARF6 (2-13)
<p>Catalogue peptide; min. 95% purity</p>Formule :C60H102N16O17Masse moléculaire :1,319.58 g/molA-K-R-R-R-L-S-S-L-R-A
<p>Catalogue peptide; min. 95% purity</p>Formule :C54H104N24O14Masse moléculaire :1,313.58 g/mol[pY185]MAP (177-189) kinase
<p>Catalogue peptide; min. 95% purity</p>Formule :C67H100N18O22Masse moléculaire :1,509.65 g/molRF-amide, Chicken
<p>Catalogue peptide; min. 95% purity</p>Formule :C32H53N9O5Masse moléculaire :643.84 g/molgp100 (177-186)
<p>Catalogue peptide; min. 95% purity</p>Formule :C45H76N12O15S2Masse moléculaire :1,089.31 g/molAZD5069
CAS :<p>AZD5069 is a small molecule that serves as a potent and selective antagonist of the CXC chemokine receptor 2 (CXCR2). It is derived from synthetic pharmaceutical research efforts aimed at targeting key signaling pathways in inflammatory diseases. This compound functions by inhibiting the CXCR2 receptor, which plays a critical role in the recruitment and activation of neutrophils, a type of white blood cell involved in inflammation and immune responses.</p>Formule :C18H22F2N4O5S2Degré de pureté :Min. 95%Masse moléculaire :476.52 g/molβ-Amyloid Protein Precursor 770 (135-155)
<p>Catalogue peptide; min. 95% purity</p>Formule :C116H173N35O31S2Masse moléculaire :2,617.95 g/molCalcitonin (8-32) (salmon I)
<p>Catalogue peptide; min. 95% purity</p>Formule :C119H198N36O37Masse moléculaire :2,725.06 g/molGlucagon-Like Peptide 1 (7-17)-Cys, GLP-1 (7-17)-Cys
<p>Catalogue peptide; min. 95% purity</p>Formule :C192H295N59O60SMasse moléculaire :4,421.92 g/molADR1-derived peptide
<p>Catalogue peptide; min. 95% purity</p>Formule :C65H114N22O18Masse moléculaire :1,491.77 g/molCDPKS, Syntide analog
<p>Catalogue peptide; min. 95% purity</p>Formule :C47H86N16O13Masse moléculaire :1,083.31 g/molACV trifluoroacetate salt
CAS :<p>ACV trifluoroacetate salt H-Aad (Cys-D-Val-OH)-OH trifluoroacetate salt is a nonheme iron that has been shown to be an oxidizing agent. It is used in the synthesis of antibiotics and other organic compounds. ACV trifluoroacetate salt H-Aad (Cys-D-Val-OH)-OH trifluoroacetate salt also has synthetase activity, which catalyzes the formation of a thiolate ligand from two molecules of acetyl coenzyme A (ACCOA) and one molecule of propionyl coenzyme A (PCCOA). This ligand binds to metal ions such as Fe2+, which are then reduced to Fe3+ by the metal cluster. The water ligands on the coordination sphere may be replaced by other ligands, such as lysine.</p>Formule :C14H25N3O6SDegré de pureté :Min. 95%Masse moléculaire :363.43 g/molproPT18
<p>Catalogue peptide; min. 95% purity</p>Formule :C96H163N35O23Masse moléculaire :2,175.59 g/molMMP-2/MMP-9 Substrate I, fluorogenic
<p>Catalogue peptide; min. 95% purity</p>Formule :C44H61N13O13SMasse moléculaire :1,012.1 g/molKinase Domain of Insulin Receptor (4)
<p>Catalogue peptide; min. 95% purity</p>Formule :C72H108N19O27Masse moléculaire :1,702.77 g/mol[Ile76]-TNF-a (70-80) (human)
<p>Catalogue peptide; min. 95% purity</p>Formule :C55H91N15O16Masse moléculaire :1,218.43 g/molLocustachykinin I
<p>Catalogue peptide; min. 95% purity</p>Formule :C43H63N13O11Masse moléculaire :938 g/molCK1tide
<p>Catalogue peptide; min. 95% purity</p>Formule :C64H96N18O27Masse moléculaire :1,549.58 g/molLKRApYLG-NH2
<p>Catalogue peptide; min. 95% purity</p>Formule :C38H67N12O11PMasse moléculaire :899.03 g/molMurine CMV pp 89 (170-174)
<p>Catalogue peptide; min. 95% purity</p>Formule :C29H41N7O7SMasse moléculaire :631.76 g/molBiotin-Secretin, human
<p>Catalogue peptide; min. 95% purity</p>Formule :C140H234N46O42SMasse moléculaire :5,465.80 g/molabII probe
<p>Catalogue peptide; min. 95% purity</p>Formule :C63H101N19O19SMasse moléculaire :1,460.69 g/molBiotin-[Glu1]-Gastrin I (human) (phosphorylated)
<p>Catalogue peptide; min. 95% purity</p>Formule :C107H141N22O37PS2Masse moléculaire :2,422.53 g/molDynorphin A (3-13), porcine
<p>Catalogue peptide; min. 95% purity</p>Formule :C64H114N22O12Masse moléculaire :1,383.76 g/mol[D-Pro10]-Dynorphin A (1-11), porcine
<p>Catalogue peptide; min. 95% purity</p>Formule :C63H103N21O13Masse moléculaire :1,362.66 g/molAmyloid Dan Protein (1-34)
<p>Catalogue peptide; min. 95% purity</p>Formule :C185H268N48O51S2Masse moléculaire :4,044.63 g/molα-Conotoxin GI
<p>Catalogue peptide; min. 95% purity</p>Formule :C55H76N20O18S4Masse moléculaire :1,433.63 g/molβ-Amyloid (11-22)
<p>Catalogue peptide; min. 95% purity</p>Formule :C70H102N18O18Masse moléculaire :1,483.70 g/molBiotin-LC-Protein Kinase G Substrate
<p>Catalogue peptide; min. 95% purity</p>Formule :C69H121N25O18SMasse moléculaire :1,621 g/molAc-a-CGRP (19-37) (human)
<p>Catalogue peptide; min. 95% purity</p>Formule :C88H139N25O26Masse moléculaire :1,963.24 g/molCaspase 2 Substrate 1m (ICH-1), fluorogenic
<p>Catalogue peptide; min. 95% purity</p>Formule :C33H44N6O12Masse moléculaire :716.8 g/molβ-Amyloid (13-27)
<p>Catalogue peptide; min. 95% purity</p>Formule :C84H126N24O24Masse moléculaire :1,856.09 g/mol4A/4B, Peptide (1)
<p>Catalogue peptide; min. 95% purity</p>Formule :C67H100N16O25S2Masse moléculaire :1,593.76 g/molKinase Domain of Insulin Receptor (3)
<p>Catalogue peptide; min. 95% purity</p>Formule :C72H108N19O27Masse moléculaire :1,702.77 g/molBiotin-a-CGRP (human)
<p>Catalogue peptide; min. 95% purity</p>Formule :C173H281N53O51S2Masse moléculaire :4,015.69 g/molSubstance P reversed sequence
<p>Catalogue peptide; min. 95% purity</p>Formule :C63H98N18O13SMasse moléculaire :1,347.66 g/molSarafotoxin S6d
<p>Catalogue peptide; min. 95% purity</p>Formule :C112H167N27O34S5Masse moléculaire :2,596 g/molGPC3 (298-306), mouse
<p>Catalogue peptide; min. 95% purity</p>Formule :C51H81N9O18Masse moléculaire :1,108.26 g/mol[Phe7] Dynorphin A (1-7), amide, porcine
<p>Catalogue peptide; min. 95% purity</p>Formule :C43H59N11O8Masse moléculaire :858.02 g/molCys-Gly-His-Gly-Asn-Lys-Ser-Amyloid β-Protein (33-40)
<p>Catalogue peptide; min. 95% purity</p>Formule :C58H99N19O18S2Masse moléculaire :1,414.67 g/molAntho-Rwamide II
<p>Catalogue peptide; min. 95% purity</p>Formule :C30H44N10O6Masse moléculaire :640.79 g/molEpidermal Mitosis Inhibiting Pentapeptide
<p>Catalogue peptide; min. 95% purity</p>Formule :C19H27N5O12Masse moléculaire :517.45 g/molInterleukin II (60-70)
<p>Catalogue peptide; min. 95% purity</p>Formule :C68H104N14O14SMasse moléculaire :1,373.74 g/molβ-Endorphin (1-5), (16-31), human
<p>Catalogue peptide; min. 95% purity</p>Formule :C112H173N27O29SMasse moléculaire :2,393.86 g/mol[Tyr12]-Somatostatin-28 (1-14)
<p>Catalogue peptide; min. 95% purity</p>Formule :C65H107N23O20SMasse moléculaire :1,562.78 g/molAcyl Carrier Protein (65-74) (acid)
<p>Catalogue peptide; min. 95% purity</p>Formule :C47H74N12O16Masse moléculaire :1,063.18 g/molα-Melanocyte Stimulating Hormone [Acetyl-D-Lys11, D-Val13] (11-13) (MSHa)
<p>Catalogue peptide; min. 95% purity</p>Formule :C18H33N5O4Masse moléculaire :383.49 g/molAllatostatin VII
<p>Catalogue peptide; min. 95% purity</p>Formule :C46H69N13O13SMasse moléculaire :1,044.2 g/molParallel topology β-Amyloid modified peptide
<p>Catalogue peptide; min. 95% purity</p>Formule :C151H211N37O39SMasse moléculaire :3,199.65 g/molIL-8ra (9-29)
<p>Catalogue peptide; min. 95% purity</p>Formule :C112H150N24O38S2Masse moléculaire :2,504.71 g/molOrn8, Urotensin II, human
<p>Catalogue peptide; min. 95% purity</p>Formule :C63H85N13O18S2Masse moléculaire :1,376.60 g/molAc-β-Endorphin, bovine, camel, ovine
<p>Catalogue peptide; min. 95% purity</p>Formule :C157H252N42O45SMasse moléculaire :3,479.99 g/molDynorphin A (1-11), porcine
<p>Catalogue peptide; min. 95% purity</p>Formule :C63H103N21O13Masse moléculaire :1,362.66 g/molβ-Interleukin I (163-171), human
<p>Catalogue peptide; min. 95% purity</p>Formule :C39H64N12O19Masse moléculaire :1,005.01 g/molLeucopyrokinin (LPK)
<p>Catalogue peptide; min. 95% purity</p>Formule :C42H66N12O12Masse moléculaire :931.06 g/molγ-TAC4 (32-50)
<p>Catalogue peptide; min. 95% purity</p>Formule :C92H146N24O31Masse moléculaire :2,084.33 g/molPhosphatase Substrate
<p>Catalogue peptide; min. 95% purity</p>Formule :C33H65N12O11PMasse moléculaire :836.95 g/mol[D-Ala2]-β-Casomorphin (1-3) amide
<p>Catalogue peptide; min. 95% purity</p>Formule :C21H26N4O4Masse moléculaire :398.47 g/mol[D-Ala2] Deltorphin II
<p>Catalogue peptide; min. 95% purity</p>Formule :C38H54N8O10Masse moléculaire :782.90 g/molβ-Amyloid (1-28)
<p>Catalogue peptide; min. 95% purity</p>Formule :C145H209N41O46Masse moléculaire :3,262.53 g/molβ-Amyloid (30-16)
<p>Catalogue peptide; min. 95% purity</p>Formule :C86H126N24O21S2Masse moléculaire :1,896.22 g/molβ-Endorphin (27-31) (human)
<p>Catalogue peptide; min. 95% purity</p>Formule :C28H45N7O9Masse moléculaire :623.71 g/molNTB (Naltriben)
<p>Catalogue peptide; min. 95% purity</p>Formule :C50H65N11O11S2Masse moléculaire :1,060.29 g/mol[Des-Asp10]Decorsin, Leech
<p>Catalogue peptide; min. 95% purity</p>Formule :C175H272N54O59S6Masse moléculaire :4,268.78 g/molδ-Endorphin
<p>Catalogue peptide; min. 95% purity</p>Formule :C83H131N19O27SMasse moléculaire :1,859.14 g/molPhosphorylase Kinase b-Subunit Fragment (420-436)
<p>Catalogue peptide; min. 95% purity</p>Formule :C79H130N31O25SMasse moléculaire :1,946.13 g/mol[D-Phe7, D-Trp10]-Somatostatin 14 (7-14)
<p>Catalogue peptide; min. 95% purity</p>Masse moléculaire :1,049.3 g/molLeucokinin V
<p>Catalogue peptide; min. 95% purity</p>Formule :C35H46N10O11Masse moléculaire :782.8 g/molMBP (90-106), phosphorylated
<p>Catalogue peptide; min. 95% purity</p>Formule :C89H141N25O22Masse moléculaire :1,913.27 g/mol[Tyr0] Gastric Inhibitory Peptide (23-42), human
<p>Catalogue peptide; min. 95% purity</p>Formule :C119H182N34O31Masse moléculaire :2,584.92 g/molHuman IgE Pentapeptide HEPP
<p>Catalogue peptide; min. 95% purity</p>Formule :C22H36N8O11Masse moléculaire :588.58 g/molCEA Related, QYSWFVNGTF
<p>Catalogue peptide; min. 95% purity</p>Formule :C61H77N13O16Masse moléculaire :1,248.37 g/mol[Ala4]-MBP (1-11)
<p>Catalogue peptide; min. 95% purity</p>Formule :C49H81N21O17Masse moléculaire :1,236.32 g/molChorionic Gonadotropin-β(109-119) amide (human)
<p>Catalogue peptide; min. 95% purity</p>Formule :C51H76N16O21SMasse moléculaire :1,269.31 g/mol[Nle253]-HSV-1 UL 26 Open Reading Frame (238-257)
<p>Catalogue peptide; min. 95% purity</p>Formule :C102H152N26O29Masse moléculaire :2,206.51 g/mol[Ala3,11,18, Nle7] Endothelin-1, human
<p>Catalogue peptide; min. 95% purity</p>Formule :C109H161N25O29S2Masse moléculaire :2,349.78 g/molPrepro VIP (111-122) (human)
<p>Catalogue peptide; min. 95% purity</p>Formule :C53H87N13O21Masse moléculaire :1,242.36 g/molα-Casomorphin (1-2)
<p>Catalogue peptide; min. 95% purity</p>Formule :C14H18N2O4Masse moléculaire :278.31 g/molHPV-E6-C
<p>Catalogue peptide; min. 95% purity</p>Formule :C110H178N36O30SMasse moléculaire :2,516.92 g/molErythromycin resistance peptide
<p>Catalogue peptide; min. 95% purity</p>Formule :C31H52N8O6SMasse moléculaire :664.86 g/molTNF-α(71-82), human
<p>Catalogue peptide; min. 95% purity</p>Formule :C51H91N19O18Masse moléculaire :1,258.41 g/molMAP Kinase Substrate
<p>Catalogue peptide; min. 95% purity</p>Formule :C101H172N30O32Masse moléculaire :2,318.66 g/mol(D-His(Bzl)6)-LHRH (1-7) (free acid)
CAS :<p>Please enquire for more information about (D-His(Bzl)6)-LHRH (1-7) (free acid) including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formule :C53H62N12O11Degré de pureté :Min. 95%Masse moléculaire :1,043.13 g/molβ-Amyloid (2-40)
<p>Catalogue peptide; min. 95% purity</p>Formule :C190H290N52O55SMasse moléculaire :4,214.81 g/mol[Met5,Arg6,7,Val8,Gly9] Enkephalin
<p>Catalogue peptide; min. 95% purity</p>Formule :C46H71N15O11SMasse moléculaire :1,042.24 g/mol[Lys0] g-1-MSH, amide
<p>Catalogue peptide; min. 95% purity</p>Formule :C78H109N23O15SMasse moléculaire :1,640.95 g/molKemptide Negative Control
<p>Catalogue peptide; min. 95% purity</p>Formule :C32H61N13O8Masse moléculaire :755.93 g/molδ1-MSH, amide
<p>Catalogue peptide; min. 95% purity</p>Formule :C72H97N21O14SMasse moléculaire :1,512.8 g/molp34cdc2-derived peptide
<p>Catalogue peptide; min. 95% purity</p>Formule :C62H104N16O19Masse moléculaire :1,377.62 g/molGalanin-Lys(Biotin), human
<p>Catalogue peptide; min. 95% purity</p>Formule :C155H237N46O46SMasse moléculaire :3,511.95 g/molF1 Peptide, lobster
<p>Catalogue peptide; min. 95% purity</p>Formule :C48H75N17O11Masse moléculaire :1,066.24 g/molMARCKS PSD-Derived Peptide, PKC Substrate
<p>Catalogue peptide; min. 95% purity</p>Formule :C75H122N20O15Masse moléculaire :1,543.93 g/mol[Lys0]-γ-1-MSH (41-58), amide
<p>Catalogue peptide; min. 95% purity</p>Masse moléculaire :1,641.1 g/molAngiotensin II Receptor, AT2, Amino Terminal Fragment
<p>Catalogue peptide; min. 95% purity</p>Formule :C79H125N23O28SMasse moléculaire :1,877.08 g/molBNP-45 ,rat
<p>Catalogue peptide; min. 95% purity</p>Formule :C213H349N71O65S3Masse moléculaire :5,040.79 g/mol[Arg8]-a-Neo-Endorphin (1-8)
<p>Catalogue peptide; min. 95% purity</p>Formule :C46H73N15O10Masse moléculaire :996.19 g/molIL-8 (-5 to +5)
<p>Catalogue peptide; min. 95% purity</p>Formule :C48H86N14O14Masse moléculaire :1,083.31 g/molSalusin-α
<p>Catalogue peptide; min. 95% purity</p>Formule :C114H192N40O30Masse moléculaire :2,602.99 g/molβ-Amyloid (18-28)
<p>Catalogue peptide; min. 95% purity</p>Formule :C55H81N13O18Masse moléculaire :1,212.34 g/molSomatostatin-28 (1-14)
<p>Catalogue peptide; min. 95% purity</p>Formule :C61H105N23O21SMasse moléculaire :1,528.72 g/molSomatostatin-14 (3-10)
<p>Catalogue peptide; min. 95% purity</p>Formule :C52H72N12O11SMasse moléculaire :1,073.28 g/molMSH Release Inhibiting Factor, amide
<p>Catalogue peptide; min. 95% purity</p>Formule :C13H24N4O3Masse moléculaire :284.36 g/molCorticostatin, rabbit
<p>Catalogue peptide; min. 95% purity</p>Formule :C163H265N63O44S6Masse moléculaire :4,003.66 g/molLF 20 Consensus Peptide. Anthrax Related Lethal Factor
<p>Catalogue peptide; min. 95% purity</p>Formule :C106H173N29O27S2Masse moléculaire :2,349.87 g/molMyelopeptide-2 (MP-2)
<p>Catalogue peptide; min. 95% purity</p>Formule :C41H57N7O8Masse moléculaire :776 g/molMMP-2/MMP-9 Inhibitor III
<p>Catalogue peptide; min. 95% purity</p>Formule :C52H73N13O14S2Masse moléculaire :1,168.35 g/molTax8, HTLV-1 (12-19)
<p>Catalogue peptide; min. 95% purity</p>Formule :C50H68N8O11Masse moléculaire :957.15 g/molGIP, porcine
<p>Catalogue peptide; min. 95% purity</p>Formule :C225H342N60O66SMasse moléculaire :4,975.66 g/molβ-Amyloid (16-26)
<p>Catalogue peptide; min. 95% purity</p>Formule :C57H86N12O17Masse moléculaire :1,211.39 g/molIntermedin (human)
<p>Catalogue peptide; min. 95% purity</p>Formule :C219H351N69O66S3Masse moléculaire :5,102.84 g/molGlucagon-Like Peptide 1, (GLP-1) amide, human
<p>Catalogue peptide; min. 95% purity</p>Formule :C184H273N51O57Masse moléculaire :4,111.53 g/mol[Arg91, Ala96]-MBP (87-99), human
<p>Catalogue peptide; min. 95% purity</p>Formule :C72H112N22O17Masse moléculaire :1,557.83 g/mol[Lys3, Phe10, Tyr13]-Autocamtide-2-Related Inhibitory Peptide (AIP) Analog
<p>Catalogue peptide; min. 95% purity</p>Formule :C74H121N23O20Masse moléculaire :1,652.93 g/molCys-Gly-Lys-Lys-Gly-Amyloid β-Protein (36-42)
<p>Catalogue peptide; min. 95% purity</p>Formule :C47H85N14O13SMasse moléculaire :1,087.35 g/mol[Tyr63] PTH (63-84), human
<p>Catalogue peptide; min. 95% purity</p>Formule :C103H172N28O37Masse moléculaire :2,394.68 g/molβ-Amyloid (22-35)
<p>Catalogue peptide; min. 95% purity</p>Formule :C59H102N16O21SMasse moléculaire :1,403.63 g/molPonatinib HCl
CAS :<p>BCR-ABL1 tyrosine kinase inhibitor</p>Formule :C29H27F3N6O·HClDegré de pureté :Min. 95%Masse moléculaire :569.02 g/molAquaporin-2 (254-267), human
<p>Catalogue peptide; min. 95% purity</p>Formule :C69H116N24O22Masse moléculaire :1,633.84 g/mol[D-Pro194]-IL-1 β (193-195) (human)
<p>Catalogue peptide; min. 95% purity</p>Formule :C15H28N4O5Masse moléculaire :344.41 g/molβ-Defensin-3, human
<p>Catalogue peptide; min. 95% purity</p>Formule :C216H371N75O59S6Masse moléculaire :5,155.22 g/molPACAP(1-38)-Lys(Biotin), amide, human, ovine, rat
<p>Catalogue peptide; min. 95% purity</p>Formule :C219H357N67O56S2Masse moléculaire :4,888.83 g/molBig Endothelin-1 (22-39), rat
<p>Catalogue peptide; min. 95% purity</p>Formule :C83H135N25O27Masse moléculaire :5,511 g/molC. difficile Toxin B (529-536)
<p>Catalogue peptide; min. 95% purity</p>Formule :C48H71N13O15Masse moléculaire :1,070.18 g/molCC Chemokine Receptor 3 Fragment I, amide
<p>Catalogue peptide; min. 95% purity</p>Formule :C142H223N35O53S2Masse moléculaire :3,332.68 g/mol[Tyr27]-pTH (27-48) (human)
<p>Catalogue peptide; min. 95% purity</p>Formule :C104H159N29O31Masse moléculaire :2,311.60 g/molTransforming Growth Factor β1 Peptide, TGF-β1 (60-66), amide
<p>Catalogue peptide; min. 95% purity</p>Formule :C45H78N12O10Masse moléculaire :947.20 g/mol[D-Trp2] Met-Enkephalin, amide
<p>Catalogue peptide; min. 95% purity</p>Formule :C36H43N7O6SMasse moléculaire :701.85 g/molParathyroid Hormone (1-34)-Lys(Biotin), human
<p>Catalogue peptide; min. 95% purity</p>Formule :C197H317N59O54S3Masse moléculaire :4,472.26 g/molAntioxidant peptide B
<p>Catalogue peptide; min. 95% purity</p>Formule :C57H91N17O15Masse moléculaire :1,254.47 g/molIL-1b (208-240) (human)
<p>Catalogue peptide; min. 95% purity</p>Formule :C191H292N48O51SMasse moléculaire :4,108.81 g/molA-A-A-Y-G-G-F-L
<p>Catalogue peptide; min. 95% purity</p>Formule :C37H52N8O10Masse moléculaire :768.87 g/molHypertrehalosaemic Neuropeptide, Nauphoeta cinerea
<p>Catalogue peptide; min. 95% purity</p>Formule :C50H67N13O14Masse moléculaire :1,074.19 g/molCarassin (Carrassius Auratus)
<p>Catalogue peptide; min. 95% purity</p>Formule :C103H175N35O27SMasse moléculaire :2,367.83 g/molDynorphin A (2-13), porcine
<p>Catalogue peptide; min. 95% purity</p>Formule :C66H117N23O13Masse moléculaire :1,440.81 g/mol[Val5,Asn9]-Angiotensin I
<p>Catalogue peptide; min. 95% purity</p>Formule :C59H86N16O15Masse moléculaire :1,259.44 g/molPrepro-adrenomedullin (153-185), human
<p>Catalogue peptide; min. 95% purity</p>Formule :C143H224N42O43Masse moléculaire :3,219.56 g/molMyosin Kinase Inhibiting Peptide
<p>Catalogue peptide; min. 95% purity</p>Formule :C40H78N18O11Masse moléculaire :987.2 g/molBiotin-Kinase Domain of Insulin Receptor (2)
<p>Catalogue peptide; min. 95% purity</p>Formule :C72H122N21O29SMasse moléculaire :1,777.92 g/molβ-Amyloid (31-35)
<p>Catalogue peptide; min. 95% purity</p>Formule :C25H47N5O6SMasse moléculaire :545.75 g/molHPV-E7-C
<p>Catalogue peptide; min. 95% purity</p>Formule :C83H128N24O40Masse moléculaire :2,102.04 g/molXenopsin (XP)
<p>Catalogue peptide; min. 95% purity</p>Formule :C47H73N13O10Masse moléculaire :980.20 g/mol
![[Ala18] Endothelin-1, human](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00289.webp&w=3840&q=75)
![[D-Pro4,D-Trp7,9,Nle11]-Substance P (4-11)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00148.webp&w=3840&q=75)
![[Lys4] Sarafotoxin S6c](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00293.webp&w=3840&q=75)
![[D-Ala2]-β-Casomorphin (1-4) amide (bovine)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00833.webp&w=3840&q=75)
![[D-Phe7] a-MSH, amide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00051.webp&w=3840&q=75)
![[pY185]MAP (177-189) kinase](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00328.webp&w=3840&q=75)
![[Ile76]-TNF-a (70-80) (human)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00637.webp&w=3840&q=75)
![Biotin-[Glu1]-Gastrin I (human) (phosphorylated)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00087.webp&w=3840&q=75)
![[D-Pro10]-Dynorphin A (1-11), porcine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00870.webp&w=3840&q=75)
![[Phe7] Dynorphin A (1-7), amide, porcine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00865.webp&w=3840&q=75)
![[Tyr12]-Somatostatin-28 (1-14)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00705.webp&w=3840&q=75)
![α-Melanocyte Stimulating Hormone [Acetyl-D-Lys11, D-Val13] (11-13) (MSHa)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00016.webp&w=3840&q=75)
![[D-Ala2]-β-Casomorphin (1-3) amide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00827.webp&w=3840&q=75)
![[D-Ala2] Deltorphin II](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00826.webp&w=3840&q=75)
![[Des-Asp10]Decorsin, Leech](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00243.webp&w=3840&q=75)
![[D-Phe7, D-Trp10]-Somatostatin 14 (7-14)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00141.webp&w=3840&q=75)
![[Tyr0] Gastric Inhibitory Peptide (23-42), human](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00928.webp&w=3840&q=75)
![[Ala4]-MBP (1-11)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00021.webp&w=3840&q=75)
![[Nle253]-HSV-1 UL 26 Open Reading Frame (238-257)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00427.webp&w=3840&q=75)
![[Ala3,11,18, Nle7] Endothelin-1, human](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00286.webp&w=3840&q=75)
![[Met5,Arg6,7,Val8,Gly9] Enkephalin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00877.webp&w=3840&q=75)
![[Lys0] g-1-MSH, amide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00562.webp&w=3840&q=75)
![[Lys0]-γ-1-MSH (41-58), amide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00561.webp&w=3840&q=75)
![[Arg8]-a-Neo-Endorphin (1-8)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00867.webp&w=3840&q=75)
![[Arg91, Ala96]-MBP (87-99), human](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00795.webp&w=3840&q=75)
![[Lys3, Phe10, Tyr13]-Autocamtide-2-Related Inhibitory Peptide (AIP) Analog](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00527.webp&w=3840&q=75)
![[Tyr63] PTH (63-84), human](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00861.webp&w=3840&q=75)
![[D-Pro194]-IL-1 β (193-195) (human)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00516.webp&w=3840&q=75)
![[Tyr27]-pTH (27-48) (human)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00893.webp&w=3840&q=75)
![[D-Trp2] Met-Enkephalin, amide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00844.webp&w=3840&q=75)
![[Val5,Asn9]-Angiotensin I](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00346.webp&w=3840&q=75)
